Mylan NV received a warning letter from the U.S. FDA for failure in ensuring the purity of active pharmaceutical ingredients made at one of its plants in Pashamyl

The US health regulator closed the  warning letter of a pharmaceutical company, Dr Reddy's Laboratories, for three of its sites in Andhra Pradesh and Telangana, after due evalua

Bayshore was notified by U.S. Food and Drug Administration (USFDA) that certain batches of Metformin Hydrochloride Extended-Release Tablets, USP 750mg, and USP 500mg when tested for

The FDA has released compliance guidelines on reserve samples used in the bioavailability and bioequivalence studies.

The guidelines:-

  &n

Tender Corporation, the firm that manufactures and distributes OTC products receives a warning letter from The U.S. Food and Drug Administration. The FDA investigators conducted

The USFDA inspected the drug manufacturing facility of Stason Pharmaceuticals, Inc., and observed significant violations of current Good Manufacturing Practice regulations for finish

Cannabis is the genus of the plant belonging to the Cannabaceae family. The three main species of Cannabis are C. sativa L., C. indica, and C. ruderalis. These spe

BD (Becton, Dickinson and Company), a leading global medical technology company announced voluntary recall for its product ChloraPrep^TM 3ml applicator due to fungal c

FDA reiterates hand sanitizers comprising low levels of ethyl alcohol or isopropyl alcohol with the dangerous presence of methanol manufactured by Eskbiochem S.A. de C.V.

The

Cadila Healthcare Limited declared that US Food and Drug Administration (FDA) furnished Form 483 with zero observations to the Baddi unit of the company.

SMS Pharmaceuticals has successfully completed its Hyderabad’s testing facility regulatory inspection by the US drug regulator.

The United States Fo

The US Food and Drug Administration (FDA) have issued a warning letter to drug manufacturing facility of KVK-Tech following an audit in April 2019.  

Aurobindo Pharma Limited stated that it has gained the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAI) status from US Food and Drug Administrati

Biocon, a drug API maker, has announced that the U.S. Food and Drug Administration (FDA) performed a Post-Approval and GMP inspection of Small Molecules API Manufacturing F

Shilpa Medicare has got 15 observations from US Food and Drug Administration (FDA) for the finished dosage formulation facility (sterile and non-sterile) for Jadcherla faci

A leading active pharmaceutical ingredient (API) provider, Solara Active Pharma Science Ltd., declared that the US Food and Drug Administration (FDA) have done two successf

The US Food and Drug Administration (FDA) revoked the status of ‘Voluntary Action Initiated’ (VAI) furnished to Unit-IV plant of Aurobindo Pharma in Hyderabad.<

Alkem Laboratories Limited has achieved 2 observations from US Food and Drug Administration (FDA) for the facility in Baddi of company in Himachal Pradesh.

The company stated

A 1st targeted consultation to the Annex 1 of the EU GMP Guide permitted about 140 companies and organizations to comment. The drafting group moved ahead with more than 6200 lines of

Reopening of investigation of Aurobindo Pharma’s Unit-4 manufacturing facility by the US Food and Drug Administration, days after the regulator had declared that it h

Biocon on Saturday stated that it has gained 3 observations from the US health regulator following inspection of its facility of insulin manufacturing in Malaysia.

The US Foo

The U.S. Food and Drug Administration (FDA) have furnished a warning letter to Greenbrier International, Inc., doing business as Dollar Tree, for getting drugs which are po

Supplier Qualification and the respective contracts in outsourcing activities are always hot debated topics in inspections. The U.S. Food and Drug Administration (FDA) rece

J. B. Chemicals & Pharmaceuticals Ltd’s US FDA granted solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat has successfully completed p

A pre-approval inspection and good manufacturing practice examination was conducted by the US health regulator at the API manufacturing facility of Biocon. The company has received a

The US Food and Drug Administration (FDA) has issued a warning letter to Health Pharma regarding its manufacturing site in New Jersey, US, after violations of current good manuf

Drug major manufacturing capabilities of Lupin have come under the scanner of the US drug regulator, as it has located deficiencies across multiple sites in recent inspections.

Lupin Ltd on Monday stated the US health regulator has alerted that its Tarapur manufacturing facility may be subjected to regulatory actions.

The company has obtained a comm

Lupin, a drug firm on Saturday stated that it has obtained two observations from the US health regulator following the inspection of its Nagpur manufacturing facility.

A PAI

The United States Food and Drug Administration (FDA) has furnished warning letter to drug firm GPT Pharmaceuticals for important violations of current good manufacturing practice (cG

Suven Life Sciences Limited recently received the EIR following the renewal inspection by US health regulator at their facility in Pashamylaram near Hyderabad for the supply and

A division of Centaur Pharmaceuticals Pvt Ltd, LifeSan Clinical Research has obtained zero Form 483 observations from US Food and Drug Administration (FDA). The company has unde

Glenmark Pharmaceuticals Ltd has obtained Certificate of good manufacturing practice (GMP) from European drug regulator for its Baddi unit in Himachal Pradesh. Glenmark's Baddi

Hikal Ltd has successfully completed USFDA audit at Panoli, Gujarat, with zero Form 483 observations.

The inspection was conducted between September 9 and 13, 2019.
As s

The US health regulator has warned Torrent Pharmaceuticals’ US-based subsidiary for violating good manufacturing practices, including the unavailability of properly designed eq

Vital violation of current Good Manufacturing Practice (cGMP) regulations was found by the health regulator of US for finished pharmaceuticals at Cadila Healthcare’s Morai

Lupin Limited received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Nagpur facility. Inspection of the facility was done by the US

Torrent Pharma is now red flagged by USFDA for significant violations of current good manufacturing practice (cGMP) regulations for its Indrad facility in Gujarat.

An inspect

As per the reports of the US health regulator, Torrent Pharma Inc is recalling 73,896 bottles of hypertension treatment tablets from the US and Puerto Rico on the basis of deviations

An inspection has been conducted by the US Food and Drug Administration officials in a manufacturing facility of Aurobindo Pharma. The FDA has observed several discrepancies regardin

Good manufacturing practice (GMP) certificate has been received by Lupin from Japan's Pharmaceutical and Medical Devices Agency (PMDA) for its drug manufacturing facility at Mandidee

Current Good Manufacturing Practices (cGMPs) are mandatory enforced by regulators of the U.S. Food and Drug Administration (FDA), and must be executed and followed by manufacturers o

Lupin, a pharma firm was red flagged by the US health regulator for significant violations of the current good manufacturing practice regulations at its Mandideep facility in Madhya

Unichem Laboratories has successfully completed the US health regulator audit of its new facility at Kolhapur, Maharashtra without any observations.

The cGMP surveillance of

The U.S. Food and Drug Administration (FDA) conducted an inspection of Hangzhou Badi Daily Use chemical company, drug manufacturing facility located at Huzhou City, Zhejiang Province from March 19

Enprani Co., Ltd drug manufacturing facility located at Incheon, was inspected by the U.S. Food and Drug Administration (FDA) from March 11 to 15, 2019.

The warning letter was issued to com

USFDA inspection was done at Haw Par Healthcare Limited drug manufacturing facility located at Singapore, from February 25 to March 1, 2019.

Issued warning letter summarized the significant

The Viralgen receives the European Medicines Agency (EMA) cGMP compliance accreditation certificate and Spanish Agency for Medicines and Health Products (AEMPS) Pharmaceutical Laboratory authorizat

The Austrian Agency for Health and Food Safety (AGES) has given the GMP compliance and pharmaceutical manufacturing license to the Rentschler Fill Solutions. It is a contact development and manufac

The US FDA inspection for Silvassa facility of Ipca Labs conducted during 19-23 August 2019. It is the formulation facility of Ipca Labs.

The firms receive three US FDA observations in Form

The US FDA inspection for Silvassa facility of Ipca Labs conducted during 19-23 August 2019. It is the formulation facility of Ipca Labs.

The firms receive three US FDA observations in Form

Three new questions and their answers are added by the USFDA to the laboratory Controls on Current Good Manufacturing Practices (cGMP) guidance. The instrument calibration standards, trial injectio

The API facility based in Mekaguda Village, near Hyderabad receives six observations from the USFDA. The inspection was carried out between05-09 August 2019.

The received observations are m

The Alathur facility of Strides based in Chennai has successfully completed the USFDA audit with zero observation. The inspection was done between 05August to 09August 2019 with no observation from

The USFDA has issued Establishment Inspection Report (EIR) for Lupin's Aurangabad facility. The USFDA inspection was carried out during 6 May 2019 till 15 May 2019.

The Auran

The US FDA has issued a warning letter to Emcure Pharma for its Pune based plant. It was made due to violation of current good manufacturing practices (cGMP) by the organization.

The US FDA

The USFDA has done the audit of Cadila Healthcare’s facility based at Ankleshwar in Gujarat. The facility is involved in the manufacturing of active pharmaceutical ingredients.

The US

After the fear of mislabeled vials, Bayer has voluntarily recalled 2 lots of 2000 IU vials (recombinant) containing Kogenate FS antihemophilic factor in the United States. Even though the labels in

Granules India completes the USFDA audit of its Bonthapally facility with one observation. It is amongst the world’s largest single site manufacturing plant of Paracetamol API by volume. The

The FDA has recommended that the patients should not use the drugs manufactured by Herbal Doctor Remedies, Monterey Park, California, because the conditions at the manufact